• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾功能损害患者肌内注射后阿米卡星的处置动力学

Disposition kinetics of amikacin in patients with renal impairment after intramuscular administration.

作者信息

Lanao J M, Dominguez-Gil A, Tabernero J M, Molina H D

出版信息

Int J Clin Pharmacol Ther Toxicol. 1982 Jun;20(6):271-5.

PMID:7107075
Abstract

The disposition kinetics of amikacin were established in 12 patients with varying degrees of renal impairment (Clcr less than 70 ml/min) after i.m. administration of a dose of 7.5 mg antibiotic/kg body wt. Administered intramuscularly, amikacin follows a single-compartment open kinetic model. A decrease may be observed in the absorption and elimination processes in this kind of patient, and mathematical relationships may be established between the variation in the pharmacokinetic parameters and the creatinine clearance. The decrease observed in the elimination constant of amikacin is similar to that observed after i.v. administration of the antibiotic. A dosage regimen for administration of the antibiotic is proposed for this kind of patient on the basis of desired peak and trough serum levels obtained throughout treatment.

摘要

对12例不同程度肾功能损害(肌酐清除率低于70 ml/min)的患者,静脉注射7.5 mg抗生素/千克体重剂量的丁胺卡那霉素后,确定了其处置动力学。丁胺卡那霉素经肌肉注射后,遵循单室开放动力学模型。在这类患者中,吸收和消除过程可能会出现下降,并且可以在药代动力学参数变化与肌酐清除率之间建立数学关系。丁胺卡那霉素消除常数的下降与静脉注射该抗生素后观察到的情况相似。根据整个治疗过程中获得的预期峰浓度和谷浓度血清水平,为这类患者提出了抗生素给药方案。

相似文献

1
Disposition kinetics of amikacin in patients with renal impairment after intramuscular administration.肾功能损害患者肌内注射后阿米卡星的处置动力学
Int J Clin Pharmacol Ther Toxicol. 1982 Jun;20(6):271-5.
2
Pharmacokinetics of Amikacin (BB-K8) in patients with normal or impaired renal function.阿米卡星(BB-K8)在肾功能正常或受损患者中的药代动力学。
Int J Clin Pharmacol Biopharm. 1979 Apr;17(4):171-5.
3
Pharmacokinetics of amikacin (BB-K8) in patients undergoing hemodialysis.阿米卡星(BB-K8)在血液透析患者中的药代动力学。
Int J Clin Pharmacol Biopharm. 1979 Aug;17(8):357-60.
4
The influence of ascites on the pharmacokinetics of amikacin.腹水对阿米卡星药代动力学的影响。
Int J Clin Pharmacol Ther Toxicol. 1980;18(2):57-61.
5
Influence of type of dialyzer on the pharmacokinetics of amikacin.透析器类型对阿米卡星药代动力学的影响。
Int J Clin Pharmacol Ther Toxicol. 1983 Apr;21(4):197-202.
6
Pharmacokinetics of amikacin in children with normal and impaired renal function.阿米卡星在肾功能正常和受损儿童中的药代动力学。
Kidney Int. 1981 Jul;20(1):115-21. doi: 10.1038/ki.1981.112.
7
Influence of the route of administration on the pharmacokinetics of amikacin.给药途径对阿米卡星药代动力学的影响。
Eur J Clin Pharmacol. 1981;19(5):367-70. doi: 10.1007/BF00544588.
8
[Comparative pharmacokinetics of amikacin after intravenous, intramuscular and subcutaneous administration].[阿米卡星静脉注射、肌肉注射和皮下注射后的比较药代动力学]
Nouv Presse Med. 1979 Oct 31;8(42):3421-5.
9
[Kinetics of multiple-dose amikacin in the newborn infant].[新生儿多剂量阿米卡星的动力学]
Ann Anesthesiol Fr. 1981;22(2):212-8.
10
Pharmacokinetics of amikacin in pony foals after a single intramuscular injection.
Am J Vet Res. 1986 Feb;47(2):453-4.

引用本文的文献

1
Use of aminoglycosides in elderly patients. Pharmacokinetic and clinical considerations.老年患者中氨基糖苷类药物的使用。药代动力学及临床考量。
Drugs Aging. 1997 Apr;10(4):259-77. doi: 10.2165/00002512-199710040-00003.